Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production

Ting Feng, Hongwei Qin, Lanfang Wang, Etty N. Benveniste, Charles O. Elson, Yingzi Cong

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Both Th1 and Th17 cells have been implicated in the pathogenesis of inflammatory bowel disease and experimental colitis. However, the complex relationship between Th1 and Th17 cells and their relative contributions to the pathogenesis of inflammatory bowel disease have not been completely analyzed. Although it has been recently shown that Th17 cells can convert into Th1 cells, the underlying in vivo mechanisms and the role of Th1 cells converted from Th17 cells in the pathogenesis of colitis are still largely unknown. In this study, we report that Th17 cells from CBir1 TCR transgenic mice, which are specific for an immunodominant microbiota Ag, are more potent than Th1 cells in the induction of colitis, as Th17 cells induced severe colitis, whereas Th1 cells induced mild colitis when transferred into TCRβxδ-/- mice. High levels of IL-12 and IL-23 and substantial numbers of IFN- γ+ Th1 cells emerged in the colons of Th17 cell recipients. Administration of anti - IL-17 mAb abrogated Th17 cell-induced colitis development, blocked colonic IL-12 and IL-23 production, and inhibited IFN-γ+ Th1 cell induction. IL-17 promoted dendritic cell production of IL-12 and IL-23. Furthermore, conditioned media from colonic tissues of colitic Th17 cell recipients induced IFN-γ production by Th17 cells, which was inhibited by blockade of IL-12 and IL-23. Collectively, these data indicate that Th17 cells convert to Th1 cells through IL-17 induction of mucosal innate IL-12 and IL-23 production.

Original languageEnglish (US)
Pages (from-to)6313-6318
Number of pages6
JournalJournal of Immunology
Volume186
Issue number11
DOIs
StatePublished - Jun 1 2011

Fingerprint

Interleukin-23
Th17 Cells
Th1 Cells
Interleukin-17
Colitis
Interleukin-12
Inflammatory Bowel Diseases
Microbiota
Conditioned Culture Medium
Dendritic Cells
Transgenic Mice
Colon

ASJC Scopus subject areas

  • Immunology

Cite this

Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. / Feng, Ting; Qin, Hongwei; Wang, Lanfang; Benveniste, Etty N.; Elson, Charles O.; Cong, Yingzi.

In: Journal of Immunology, Vol. 186, No. 11, 01.06.2011, p. 6313-6318.

Research output: Contribution to journalArticle

Feng, Ting ; Qin, Hongwei ; Wang, Lanfang ; Benveniste, Etty N. ; Elson, Charles O. ; Cong, Yingzi. / Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. In: Journal of Immunology. 2011 ; Vol. 186, No. 11. pp. 6313-6318.
@article{25b88913740745d0bd8a2e5b79f966f0,
title = "Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production",
abstract = "Both Th1 and Th17 cells have been implicated in the pathogenesis of inflammatory bowel disease and experimental colitis. However, the complex relationship between Th1 and Th17 cells and their relative contributions to the pathogenesis of inflammatory bowel disease have not been completely analyzed. Although it has been recently shown that Th17 cells can convert into Th1 cells, the underlying in vivo mechanisms and the role of Th1 cells converted from Th17 cells in the pathogenesis of colitis are still largely unknown. In this study, we report that Th17 cells from CBir1 TCR transgenic mice, which are specific for an immunodominant microbiota Ag, are more potent than Th1 cells in the induction of colitis, as Th17 cells induced severe colitis, whereas Th1 cells induced mild colitis when transferred into TCRβxδ-/- mice. High levels of IL-12 and IL-23 and substantial numbers of IFN- γ+ Th1 cells emerged in the colons of Th17 cell recipients. Administration of anti - IL-17 mAb abrogated Th17 cell-induced colitis development, blocked colonic IL-12 and IL-23 production, and inhibited IFN-γ+ Th1 cell induction. IL-17 promoted dendritic cell production of IL-12 and IL-23. Furthermore, conditioned media from colonic tissues of colitic Th17 cell recipients induced IFN-γ production by Th17 cells, which was inhibited by blockade of IL-12 and IL-23. Collectively, these data indicate that Th17 cells convert to Th1 cells through IL-17 induction of mucosal innate IL-12 and IL-23 production.",
author = "Ting Feng and Hongwei Qin and Lanfang Wang and Benveniste, {Etty N.} and Elson, {Charles O.} and Yingzi Cong",
year = "2011",
month = "6",
day = "1",
doi = "10.4049/jimmunol.1001454",
language = "English (US)",
volume = "186",
pages = "6313--6318",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production

AU - Feng, Ting

AU - Qin, Hongwei

AU - Wang, Lanfang

AU - Benveniste, Etty N.

AU - Elson, Charles O.

AU - Cong, Yingzi

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Both Th1 and Th17 cells have been implicated in the pathogenesis of inflammatory bowel disease and experimental colitis. However, the complex relationship between Th1 and Th17 cells and their relative contributions to the pathogenesis of inflammatory bowel disease have not been completely analyzed. Although it has been recently shown that Th17 cells can convert into Th1 cells, the underlying in vivo mechanisms and the role of Th1 cells converted from Th17 cells in the pathogenesis of colitis are still largely unknown. In this study, we report that Th17 cells from CBir1 TCR transgenic mice, which are specific for an immunodominant microbiota Ag, are more potent than Th1 cells in the induction of colitis, as Th17 cells induced severe colitis, whereas Th1 cells induced mild colitis when transferred into TCRβxδ-/- mice. High levels of IL-12 and IL-23 and substantial numbers of IFN- γ+ Th1 cells emerged in the colons of Th17 cell recipients. Administration of anti - IL-17 mAb abrogated Th17 cell-induced colitis development, blocked colonic IL-12 and IL-23 production, and inhibited IFN-γ+ Th1 cell induction. IL-17 promoted dendritic cell production of IL-12 and IL-23. Furthermore, conditioned media from colonic tissues of colitic Th17 cell recipients induced IFN-γ production by Th17 cells, which was inhibited by blockade of IL-12 and IL-23. Collectively, these data indicate that Th17 cells convert to Th1 cells through IL-17 induction of mucosal innate IL-12 and IL-23 production.

AB - Both Th1 and Th17 cells have been implicated in the pathogenesis of inflammatory bowel disease and experimental colitis. However, the complex relationship between Th1 and Th17 cells and their relative contributions to the pathogenesis of inflammatory bowel disease have not been completely analyzed. Although it has been recently shown that Th17 cells can convert into Th1 cells, the underlying in vivo mechanisms and the role of Th1 cells converted from Th17 cells in the pathogenesis of colitis are still largely unknown. In this study, we report that Th17 cells from CBir1 TCR transgenic mice, which are specific for an immunodominant microbiota Ag, are more potent than Th1 cells in the induction of colitis, as Th17 cells induced severe colitis, whereas Th1 cells induced mild colitis when transferred into TCRβxδ-/- mice. High levels of IL-12 and IL-23 and substantial numbers of IFN- γ+ Th1 cells emerged in the colons of Th17 cell recipients. Administration of anti - IL-17 mAb abrogated Th17 cell-induced colitis development, blocked colonic IL-12 and IL-23 production, and inhibited IFN-γ+ Th1 cell induction. IL-17 promoted dendritic cell production of IL-12 and IL-23. Furthermore, conditioned media from colonic tissues of colitic Th17 cell recipients induced IFN-γ production by Th17 cells, which was inhibited by blockade of IL-12 and IL-23. Collectively, these data indicate that Th17 cells convert to Th1 cells through IL-17 induction of mucosal innate IL-12 and IL-23 production.

UR - http://www.scopus.com/inward/record.url?scp=79958025270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958025270&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1001454

DO - 10.4049/jimmunol.1001454

M3 - Article

VL - 186

SP - 6313

EP - 6318

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -